Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders

Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders

US Patent 12285397 · Granted Apr 29, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating developmental disorders with gaboxadol2025
Methods and compositions for treatment of epileptic disorders2024
Methods and compositions for treatment of epileptic disorders2024
Methods of treating seizure disorders and Prader-Willi syndrome2024
Methods and compositions for treatment of epileptic disorders2024
Methods and compositions for treatment of epileptic disorders2024
Methods and compositions for treatment of epileptic disorders2023
Use of (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid an2023
Use of MIR101 or MIR128 in the treatment of seizure disorders2023
Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder2023
Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and 2023
Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and 2023